Literature DB >> 12120247

Role of endoscopic ultrasound in the diagnosis of cystic lesions of the pancreas.

W R Brugge1.   

Abstract

Endoscopic ultrasound (EUS) is an ideal imaging technique for pancreatic cystic lesions. Ultrasound is exquisitely sensitive for detecting and characterizing cysts arising in solid organs, and when the transducer is placed on an endoscope, high resolution imaging of the pancreas is achieved. Linear EUS can also guide needle aspiration of pancreatic cystic lesions and through the use of aspiration cytology, cystic tumors of the pancreas can be diagnosed. Since cytology is a relatively insensitive test, cyst fluid tumor markers such as CEA have been employed to improve the sensitivity for the detection of malignancy. Cyst fluid CEA values are uniformly low in serous cystadenomas, higher in mucinous lesions, and markedly elevated in mucinous cystadenocarcinomas. Through the use of these techniques, the ability to detect and diagnose early malignancies of the pancreas will be greatly enhanced.

Entities:  

Mesh:

Year:  2001        PMID: 12120247     DOI: 10.1159/000055874

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  10 in total

1.  Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma.

Authors:  Ji Kon Ryu; Hanno Matthaei; Marco Dal Molin; Seung-Mo Hong; Marcia I Canto; Richard D Schulick; Christopher Wolfgang; Michael G Goggins; Ralph H Hruban; Leslie Cope; Anirban Maitra
Journal:  Pancreatology       Date:  2011-07-12       Impact factor: 3.996

2.  The value of cyst fluid analysis in the pre-operative evaluation of pancreatic cysts.

Authors:  Martha Bishop Pitman; William R Brugge; Andrew L Warshaw
Journal:  J Gastrointest Oncol       Date:  2011-12

3.  Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment.

Authors:  Jennifer F Tseng; Andrew L Warshaw; Dushyant V Sahani; Gregory Y Lauwers; David W Rattner; Carlos Fernandez-del Castillo
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

4.  [Indications for pancreatic biopsy. Uncommon, but increasingly more important].

Authors:  J-M Löhr; G Klöppel
Journal:  Pathologe       Date:  2005-02       Impact factor: 1.011

Review 5.  Endoscopic ultrasound-guided fine-needle aspiration cytology diagnosis of solid pseudopapillary tumor of the pancreas: a case report and literature review.

Authors:  Charitini Salla; Paschalis Chatzipantelis; Panagiotis Konstantinou; Ioannis Karoumpalis; Akrivi Pantazopoulou; Victoria Dappola
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

Review 6.  Management of serous cystadenoma of the pancreas.

Authors:  Jennifer F Tseng
Journal:  J Gastrointest Surg       Date:  2007-10-25       Impact factor: 3.452

Review 7.  Current perspectives on pancreatic serous cystic neoplasms: Diagnosis, management and beyond.

Authors:  Xiao-Peng Zhang; Zhong-Xun Yu; Yu-Pei Zhao; Meng-Hua Dai
Journal:  World J Gastrointest Surg       Date:  2016-03-27

8.  Accuracy of diagnosis of solid pseudopapillary tumor of the pancreas on fine needle aspiration: A multi-institution experience of ten cases.

Authors:  Sidra Jahangir; Asif Loya; Momin T Siddiqui; Noreen Akhter; Muhammed Aasim Yusuf
Journal:  Cytojournal       Date:  2015-12-04       Impact factor: 2.091

9.  Endoscopic ultrasound-guided drainage of pancreatic pseudocysts.

Authors:  Adrian Saftoiu; Andreas Vilmann; Peter Vilmann
Journal:  Endosc Ultrasound       Date:  2015 Oct-Dec       Impact factor: 5.628

10.  Middle segment pancreatectomy for a solid serous cystadenoma diagnosed by MRCP and review of the literature: A case report.

Authors:  Yuichiro Okumura; Takehiro Noda; Hidetoshi Eguchi; Yoshifumi Iwagami; Daisaku Yamada; Tadafumi Asaoka; Koichi Kawamoto; Kunihito Gotoh; Shogo Kobayashi; Koji Umeshita; Yasuji Hashimoto; Yutaka Takeda; Masahiro Tanemura; Minoru Shigekawa; Eiichi Morii; Tetsuo Takehara; Masaki Mori; Yuichiro Doki
Journal:  Mol Clin Oncol       Date:  2018-03-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.